Robotic surgery in rectal cancer: advantages and limitations

Robotic surgery represents the latest technological advance in the surgical treatment of rectal cancer. The robotic system (the best known being Da Vinci) provides the surgeon with articulated instruments with a wider range of motion, high-definition 3D visualization and enhanced precision — particularly valuable in the narrow space of the pelvis.

What robotic surgery is

How it works

Robotic surgery does not mean that a robot operates autonomously. The surgeon controls every movement at all times:

1. The surgeon sits at a console equipped with 3D visualization and manual controls
2. The robot (mechanical arms) translates the surgeon’s movements into precise, scaled-down movements inside the patient
3. Assistants stand near the patient and change instruments when needed

The Da Vinci system

The most widespread robotic surgical system in the world:

• 4 robotic arms — 3 for instruments, 1 for the camera
• 3D camera with up to 10x magnification
• EndoWrist instruments — articulate with 7 degrees of freedom (the human hand has only 4)
• Tremor filtering — eliminates the surgeon’s physiological hand tremor
• Motion scaling — the surgeon’s larger movements are translated into fine instrument movements

Why robotic surgery is advantageous in rectal cancer

Pelvic challenges

The standard operation for rectal cancer — total mesorectal excision (TME) — involves dissection in the narrow pelvic space, around the rectum. This area is difficult for several reasons:

• Limited space — the bony pelvis restricts access, especially in men and obese patients
• Delicate adjacent structures — autonomic nerves (sexual and urinary), ureters, iliac vessels
• Need for precise dissection — the TME surgical plane must be followed exactly to obtain clear margins and preserve nerves
• Low tumors — the closer the tumor is to the anus, the more difficult dissection becomes

Advantages of the robot in the pelvis

Superior visualization:

• Stable 3D camera, controlled by the surgeon (not by an assistant)
• Magnification — allows identification of nerves and fine tissue planes
• No camera “fatigue” — stable image throughout the operation

Articulation and dexterity:

• Robotic instruments articulate inside the pelvis — a major difference from laparoscopy, where instruments are rigid
• Allows suturing and dissection at angles impossible with straight instruments
• Particularly useful for anterior dissection (in front of the rectum, near the prostate or vagina)

Ergonomics for the surgeon:

• The surgeon sits at the console in a comfortable position
• Reduces fatigue in long operations (3-5 hours)
• Surgeon fatigue affects performance — reducing it benefits the patient

Robotic vs. laparoscopic vs. open surgery

Feature	Open	Laparoscopic	Robotic
Incision	Large (15-25 cm)	4-5 small incisions (1-2 cm)	4-5 small incisions (1-2 cm)
Visualization	Direct 2D	2D camera	3D camera with magnification
Pelvic dexterity	Maximum (hands)	Limited (rigid instruments)	Excellent (articulated instruments)
Postoperative pain	Higher	Reduced	Reduced
Hospital stay	7-10 days	4-7 days	4-7 days
Recovery	6-8 weeks	3-5 weeks	3-5 weeks
Blood loss	Higher	Reduced	Reduced
Conversion to open surgery	N/A	5-15%	3-8%
Cost	Lowest	Intermediate	Highest

Outcomes — what studies show

Oncological quality

• TME specimen quality (mesorectal integrity) — robotic is equivalent or superior to laparoscopy
• Resection margins — similar rates of positive margins (3-5%)
• Number of harvested nodes — similar (mean 15-20 nodes)
• Locoregional recurrence — similar rates at 3-5 years
• Survival — no significant differences between methods

Functional outcomes

This is where robotic surgery may offer a real advantage:

Sexual function:

• Studies suggest better recovery rates of erectile function in men after robotic surgery (due to superior nerve visualization)
• Differences are more evident in low tumors, where dissection is closer to the cavernous nerves

Urinary function:

• A trend toward faster recovery of urinary function after robotic
• Differences are modest and not consistent across all studies

Bowel function:

• LARS scores are similar between robotic and laparoscopic
• Bowel function depends more on the level of the anastomosis than on the surgical method. Assess the risk with the POLARS calculator

Conversion rate

• Robotic: 3-8% conversion rate to open surgery
• Laparoscopy: 5-15% conversion rate
• The difference is more pronounced in obese patients and in men with a narrow pelvis

Specific indications

When robotic is particularly useful

• Low rectal tumors — the limited pelvic space benefits most from articulated instruments
• Obese men — the narrow, fatty pelvis makes laparoscopy very difficult
• Patients with narrow pelvis (difficult anatomy)
• When nerve preservation is desired — superior visualization helps identify and preserve nerves
• Intersphincteric resection — extremely difficult procedure that benefits from robotic precision

When it is NOT necessary

• High rectal tumors — at this location, standard laparoscopy provides excellent results
• Colon cancer — the advantage of robotic is minimal (ample space, no pelvic constraints)
• Surgical emergencies — robot setup takes time

Limitations of robotic surgery

Technical limitations

• No tactile feedback — the surgeon does not “feel” the tissues (can be compensated by visual experience)
• Instrument size — robotic arms require minimum space to operate
• Setup time (docking) — configuring the robot adds 20-40 minutes to surgery duration
• Technical malfunctions — rare but may require conversion to laparoscopy or open surgery

Practical limitations

• Cost — the Da Vinci system costs 1.5-2.5 million euros; instruments are single-use
• Learning curve — the surgeon needs 20-40 cases to become competent
• Availability — the number of surgical robots is limited
• Operation duration — slightly longer than laparoscopy in the hands of a surgeon with equal experience in both techniques

Scientific limitations

• There is not yet a large randomized study showing clear superiority of robotic over laparoscopic in rectal cancer
• The ROLARR trial (2017) showed no significant differences in conversion rate
• More recent studies (REAL, COLRAR) are ongoing and will provide clearer data

Questions to ask the surgeon

1. “Do you have experience with robotic surgery for rectal cancer?”
2. “How many robotic operations have you performed?” (ideally over 30-50 for competence)
3. “What are the advantages of robotic in my specific case?”
4. “Is there a laparoscopic alternative that is equally good for my tumor?”
5. “What is your conversion rate?”
6. “How is the cost covered — by insurance or out-of-pocket?”

The future of robotic surgery

Emerging trends

• Single-port robotic surgery — the SP Da Vinci platform
• ICG (indocyanine green) fluorescence — real-time visualization of vascularization and lymph nodes
• Augmented reality — overlaying MRI images on the operative field
• Artificial intelligence — assistance in identifying anatomical structures and dissection planes
• New platforms — Versius (CMR Surgical), Hugo (Medtronic) — will reduce costs through competition

---

This article is for informational purposes only and does not replace medical consultation. Discuss with your surgeon about the most appropriate surgical technique for your case.